Annual Total Liabilities
N/A
December 1, 2024
Summary
- PFE annual total liabilities is not available.
Performance
PFE Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Total Liabilities
N/A
December 1, 2024
Summary
- PFE quarterly total liabilities is not available.
Performance
PFE Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Total Liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
PFE Total Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | - |
| 3 y3 years | - | - |
| 5 y5 years | - | - |
PFE Total Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | ||||
| 5 y | 5-year | ||||
| alltime | all time |
Pfizer Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $126.92 B(-1.0%) |
| Jun 2024 | - | $128.22 B(-0.2%) |
| Mar 2024 | - | $128.54 B(-6.3%) |
| Dec 2023 | $137.21 B(+35.5%) | $137.21 B(+16.5%) |
| Sep 2023 | - | $117.82 B(-2.5%) |
| Jun 2023 | - | $120.88 B(+28.1%) |
| Mar 2023 | - | $94.38 B(-6.8%) |
| Dec 2022 | $101.29 B(-2.6%) | $101.29 B(-1.1%) |
| Sep 2022 | - | $102.46 B(-5.0%) |
| Jun 2022 | - | $107.82 B(+6.6%) |
| Mar 2022 | - | $101.16 B(-2.7%) |
| Dec 2021 | $104.01 B(+14.6%) | $104.01 B(+0.8%) |
| Sep 2021 | - | $103.22 B(+3.6%) |
| Jun 2021 | - | $99.61 B(+10.7%) |
| Mar 2021 | - | $89.95 B(-0.9%) |
| Dec 2020 | $90.76 B(-12.9%) | $90.76 B(-20.0%) |
| Sep 2020 | - | $113.49 B(+0.1%) |
| Jun 2020 | - | $113.37 B(+12.2%) |
| Mar 2020 | - | $101.00 B(-3.0%) |
| Dec 2019 | $104.15 B(+8.9%) | $104.15 B(-0.9%) |
| Sep 2019 | - | $105.05 B(+9.1%) |
| Jun 2019 | - | $96.28 B(+0.0%) |
| Mar 2019 | - | $96.26 B(+0.6%) |
| Dec 2018 | $95.66 B(-4.5%) | $95.66 B(-0.5%) |
| Sep 2018 | - | $96.17 B(+1.4%) |
| Jun 2018 | - | $94.86 B(+0.8%) |
| Mar 2018 | - | $94.07 B(-6.1%) |
| Dec 2017 | $100.14 B(-10.4%) | $100.14 B(-9.8%) |
| Sep 2017 | - | $111.04 B(+1.1%) |
| Jun 2017 | - | $109.86 B(-0.2%) |
| Mar 2017 | - | $110.04 B(-1.6%) |
| Dec 2016 | $111.78 B(+9.2%) | $111.78 B(-2.7%) |
| Sep 2016 | - | $114.83 B(+6.7%) |
| Jun 2016 | - | $107.59 B(+8.0%) |
| Mar 2016 | - | $99.58 B(-2.7%) |
| Dec 2015 | $102.38 B(+6.7%) | $102.38 B(-1.3%) |
| Sep 2015 | - | $103.74 B(+10.7%) |
| Jun 2015 | - | $93.70 B(+0.7%) |
| Mar 2015 | - | $93.05 B(-3.0%) |
| Dec 2014 | $95.94 B(+0.5%) | $95.94 B(+3.1%) |
| Sep 2014 | - | $93.06 B(-2.7%) |
| Jun 2014 | - | $95.66 B(+2.0%) |
| Mar 2014 | - | $93.74 B(-1.8%) |
| Dec 2013 | $95.48 B(-8.3%) | $95.48 B(-1.7%) |
| Sep 2013 | - | $97.17 B(-3.2%) |
| Jun 2013 | - | $100.36 B(-4.0%) |
| Mar 2013 | - | $104.57 B(+0.4%) |
| Dec 2012 | $104.12 B(-1.2%) | $104.12 B(+3.6%) |
| Sep 2012 | - | $100.49 B(-2.3%) |
| Jun 2012 | - | $102.88 B(+0.9%) |
| Mar 2012 | - | $102.01 B(-3.2%) |
| Dec 2011 | $105.38 B(-1.3%) | $105.38 B(-0.2%) |
| Sep 2011 | - | $105.60 B(-1.2%) |
| Jun 2011 | - | $106.94 B(+2.4%) |
| Mar 2011 | - | $104.42 B(-2.2%) |
| Dec 2010 | $106.75 B(-12.9%) | $106.75 B(+3.3%) |
| Sep 2010 | - | $103.35 B(-0.8%) |
| Jun 2010 | - | $104.19 B(-0.8%) |
| Mar 2010 | - | $105.03 B(-14.3%) |
| Dec 2009 | $122.50 B(+129.4%) | $122.50 B(+63.2%) |
| Sep 2009 | - | $75.04 B(-1.4%) |
| Jun 2009 | - | $76.10 B(+21.8%) |
| Mar 2009 | - | $62.49 B(+17.0%) |
| Dec 2008 | $53.41 B(+6.5%) | $53.41 B(+11.8%) |
| Sep 2008 | - | $47.76 B(-4.1%) |
| Jun 2008 | - | $49.80 B(-2.3%) |
| Mar 2008 | - | $50.99 B(+1.7%) |
| Dec 2007 | $50.14 B(+13.7%) | $50.14 B(+18.2%) |
| Sep 2007 | - | $42.42 B(+0.3%) |
| Jun 2007 | - | $42.31 B(+11.4%) |
| Mar 2007 | - | $37.99 B(-13.9%) |
| Dec 2006 | $44.11 B | $44.11 B(+13.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2006 | - | $38.87 B(-9.7%) |
| Jun 2006 | - | $43.06 B(-0.7%) |
| Mar 2006 | - | $43.35 B(-15.3%) |
| Dec 2005 | $51.21 B(-6.6%) | $51.21 B(+17.6%) |
| Sep 2005 | - | $43.54 B(-7.4%) |
| Jun 2005 | - | $47.00 B(-15.2%) |
| Mar 2005 | - | $55.40 B(+1.1%) |
| Dec 2004 | $54.80 B(+6.6%) | $54.80 B(+1.8%) |
| Sep 2004 | - | $53.85 B(+1.1%) |
| Jun 2004 | - | $53.26 B(+0.0%) |
| Mar 2004 | - | $53.24 B(+3.6%) |
| Dec 2003 | $51.40 B(+94.6%) | $51.40 B(-0.3%) |
| Sep 2003 | - | $51.53 B(-4.5%) |
| Jun 2003 | - | $53.98 B(+92.2%) |
| Mar 2003 | - | $28.09 B(+6.4%) |
| Dec 2002 | $26.41 B(+26.6%) | $26.41 B(+1.9%) |
| Sep 2002 | - | $25.92 B(+9.2%) |
| Jun 2002 | - | $23.74 B(+9.7%) |
| Mar 2002 | - | $21.64 B(+3.7%) |
| Dec 2001 | $20.86 B(+19.7%) | $20.86 B(+4.8%) |
| Sep 2001 | - | $19.91 B(+4.1%) |
| Jun 2001 | - | $19.13 B(+9.9%) |
| Mar 2001 | - | $17.40 B(-0.2%) |
| Dec 2000 | $17.43 B(+0.1%) | $17.43 B(+0.7%) |
| Sep 2000 | - | $17.32 B(+1.4%) |
| Jun 2000 | - | $17.07 B(+70.1%) |
| Mar 2000 | - | $10.04 B(-42.4%) |
| Dec 1999 | $17.42 B(+83.5%) | $17.42 B(+52.1%) |
| Sep 1999 | - | $11.45 B(+4.2%) |
| Jun 1999 | - | $10.99 B(+10.1%) |
| Mar 1999 | - | $9.98 B(+5.1%) |
| Dec 1998 | $9.49 B(+34.5%) | $9.49 B(-0.4%) |
| Sep 1998 | - | $9.53 B(+16.2%) |
| Jun 1998 | - | $8.20 B(+5.6%) |
| Mar 1998 | - | $7.77 B(+10.0%) |
| Dec 1997 | $7.06 B(-7.9%) | $7.06 B(-10.7%) |
| Sep 1997 | - | $7.90 B(-7.3%) |
| Jun 1997 | - | $8.52 B(+8.4%) |
| Mar 1997 | - | $7.86 B(+2.6%) |
| Dec 1996 | $7.66 B(+6.8%) | $7.66 B(-4.2%) |
| Sep 1996 | - | $8.00 B(+5.4%) |
| Jun 1996 | - | $7.59 B(+4.8%) |
| Mar 1996 | - | $7.24 B(+0.9%) |
| Dec 1995 | $7.18 B(+6.5%) | $7.18 B(-4.2%) |
| Sep 1995 | - | $7.49 B(-7.2%) |
| Jun 1995 | - | $8.07 B(+3.8%) |
| Mar 1995 | - | $7.78 B(+15.5%) |
| Dec 1994 | $6.74 B(+24.1%) | $6.74 B(+8.5%) |
| Sep 1994 | - | $6.21 B(-1.7%) |
| Jun 1994 | - | $6.32 B(+9.5%) |
| Mar 1994 | - | $5.77 B(+6.3%) |
| Dec 1993 | $5.43 B(+12.2%) | $5.43 B(-9.9%) |
| Sep 1993 | - | $6.02 B(+4.2%) |
| Jun 1993 | - | $5.78 B(+10.3%) |
| Mar 1993 | - | $5.24 B(+8.3%) |
| Dec 1992 | $4.84 B(+5.7%) | $4.84 B(+4.5%) |
| Sep 1992 | - | $4.63 B(+3.1%) |
| Jun 1992 | - | $4.49 B(+2.7%) |
| Mar 1992 | - | $4.37 B(-4.5%) |
| Dec 1991 | $4.57 B(+16.3%) | $4.57 B(+17.1%) |
| Sep 1991 | - | $3.91 B(-1.5%) |
| Jun 1991 | - | $3.97 B(+10.0%) |
| Mar 1991 | - | $3.61 B(-8.3%) |
| Dec 1990 | $3.93 B(+4.4%) | $3.93 B(+12.7%) |
| Sep 1990 | - | $3.49 B(+2.7%) |
| Jun 1990 | - | $3.39 B(+6.4%) |
| Mar 1990 | - | $3.19 B(-15.3%) |
| Dec 1989 | $3.76 B(+12.8%) | $3.76 B(+12.8%) |
| Dec 1988 | $3.34 B(+9.7%) | $3.34 B(+9.7%) |
| Dec 1987 | $3.04 B(+73.9%) | $3.04 B(+73.9%) |
| Dec 1986 | $1.75 B(+13.9%) | $1.75 B(+13.9%) |
| Dec 1985 | $1.54 B(-1.7%) | $1.54 B(-1.7%) |
| Dec 1984 | $1.56 B | $1.56 B |
FAQ
- What is the all time high annual total liabilities for Pfizer?
- What is the all time high quarterly total liabilities for Pfizer?
What is the all time high annual total liabilities for Pfizer?
Pfizer all-time high annual total liabilities is $137.21 B
What is the all time high quarterly total liabilities for Pfizer?
Pfizer all-time high quarterly total liabilities is $137.21 B